Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012
about
Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and TreatmentEpidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniaeInfection with and Carriage of Mycoplasma pneumoniae in ChildrenRadiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia.Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implicationsMacrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, ChinaComparative genome analysis of Mycoplasma pneumoniae.Macrolide-Resistant Mycoplasma pneumoniae, United States.Molecular Detection and Characterization of Mycoplasma pneumoniae Among Patients Hospitalized With Community-Acquired Pneumonia in the United States.In vitro subminimum inhibitory concentrations of macrolide antibiotics induce macrolide resistance in Mycoplasma pneumoniaeTherapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.Mycoplasma pneumoniae Epidemiology in England and Wales: A National Perspective.Complete Genome Sequence of the Macrolide-Resistant Mycoplasma pneumoniae Strain C267 in China.Study of Two Separate Types of Macrolide-Resistant Mycoplasma pneumoniae Outbreaks.Comparison of pyrosequencing, Sanger sequencing, and melting curve analysis for detection of low-frequency macrolide-resistant mycoplasma pneumoniae quasispecies in respiratory specimens.Two case reports: Whole genome sequencing of two clinical macrolide-resistant Mycoplasma pneumoniae isolates with different responses to azithromycin.A randomized, open, multicenter clinical study on the short course of intravenous infusion of 750 mg of levofloxacin and the sequential standard course of intravenous infusion/oral administration of 500 mg of levofloxacin for treatment of community-P40 and P90 from Mpn142 are Targets of Multiple Processing Events on the Surface of Mycoplasma pneumoniaeDrug resistance mechanisms of Mycoplasma pneumoniae to macrolide antibiotics.Regional differences in antibiotic-resistant pathogens in patients with pneumonia: Implications for clinicians.The role of the PM2.5-associated metals in pathogenesis of child Mycoplasma Pneumoniae infections: a systematic review.Resistance to Macrolide Antibiotics in Public Health Pathogens.Epidemiology and Molecular Characteristics of Mycoplasma pneumoniae During an Outbreak of M. pneumoniae-associated Stevens-Johnson Syndrome.Atypical Pneumonia: Updates on Legionella, Chlamydophila, and Mycoplasma Pneumonia.Mycoplasma pneumoniae from the Respiratory Tract and Beyond.Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju.Relationships between Th1/Th2 cytokine profiles and chest radiographic manifestations in childhood Mycoplasma pneumoniae pneumonia.In vitro antibacterial activity of α-methoxyimino acylide derivatives against macrolide-resistant pathogens and mutation analysis in 23S rRNA.In Vitro Activities of Lefamulin and Other Antimicrobial Agents against Macrolide-Susceptible and Macrolide-Resistant Mycoplasma pneumoniae from the United States, Europe, and China.Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015.Galactofuranose in Mycoplasma mycoides is important for membrane integrity and conceals adhesins but does not contribute to serum resistance.Treatment of preschool children presenting to the emergency department with wheeze with azithromycin: A placebo-controlled randomized trialMacrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.Comparison of efficacy of antimicrobial agents among hospitalized patients with Mycoplasma pneumoniae pneumonia in Japan during large epidemics of macrolide-resistant M. pneumoniae infections: A nationwide observational study.First report of macrolide resistance in a Mycoplasma pneumoniae isolate causing community-acquired pneumonia in Spain.Low rate of macrolide resistance in Mycoplasma pneumoniae strains in Germany between 2009 and 2012.Mycoplasma pneumoniae: A Potentially Severe Infection.Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive Pneumonia in ChildrenMultilocus Sequence Typing of Mycoplasma pneumoniae, Japan, 2002-2016
P2860
Q26742180-D5CD3A81-A95A-4D18-8136-623B0FB65806Q26744683-9AA94CF0-38D4-44C9-98BF-F50D2F77BA7AQ26752332-0C7AA9E8-9B55-4344-800D-0826E4D0882CQ33776351-21EEB5DB-8CE4-42B4-8EAB-6F02B29704B0Q34023899-FA8DAA78-6CFB-49D2-89AC-7DFBD501D51BQ35105923-AB95F5D1-AC06-4EEC-9615-D2232EA2C7C6Q35746800-A5849AA4-28B4-48F9-9469-5436120D87A4Q35896987-2C739D69-60C4-4825-A9FF-83CF232017F4Q35952824-EDA90CE4-DEAA-4F43-8895-8E28F24CC8D7Q36071967-524B85C4-5A93-45B4-9BF5-77BBAC802750Q36306172-B51F20C5-B1D9-4952-9B99-5ECA5CA86E96Q36582458-D742D9B0-3513-41FF-9C59-EFAE586C41E4Q36776246-76001FD6-AFE2-4637-BA1E-401C5033F288Q37023122-2C7F27BC-8DF7-446C-BF05-AB10C15530CFQ37036304-3DB7D437-4B47-4E87-9076-4D9B2F4ECAECQ37300689-FDE2968B-5FDA-4F2C-99CA-A3D992838158Q37329438-FEB14433-2C9D-49C5-B54F-AC0E92A70C1CQ37566495-48817EFB-E622-42F0-BC43-521C6BD14FDFQ37586821-B94ED748-84D5-4D71-95CE-81E8E0A882BDQ38646554-FF6F0ADB-7AF6-4080-94A5-7F866385E841Q38797037-77D5173E-8A7E-4AF4-83F1-4B67488ED7D3Q38928353-9011E301-2041-4A8F-AE08-BA3A9877B6BBQ39036185-8790FCEE-DF05-4BD1-ABD9-A8932675CB0AQ39118434-F5C08A02-F710-4507-96CC-9F09130BA34DQ39327219-31003A9A-3EA1-4CEE-BF71-1F6832BC6F7DQ40065207-E8AE1101-2076-45AD-AE64-17F912C93D05Q40076841-E89946CC-ED99-44D6-8C76-F61B7BF6082FQ40377312-5B5C2864-700D-4E8B-84FB-142897873959Q40448204-3B2CE6C5-ECB9-4C7D-A6D1-EB39CE6EB521Q40868497-365DC670-715C-4841-BC1E-39FDF98348F0Q41008176-B85B69E7-C8C5-4CAB-BF58-94D3CF877EBEQ41237449-46135EA5-4E97-4492-8117-3D25E2446D09Q41774181-EBDDAC24-F08E-4BCB-94A7-D4F5BBFA4894Q41987270-BF32E76F-A053-4968-A244-B7EFEE220E77Q42692424-6A33055C-F833-4641-B5FB-914F252E0B5AQ43110648-595B3664-C99F-4225-8BBD-3EA5E028E388Q55314495-2BF79CE9-D338-456E-9C74-341EFBB05944Q57807299-CF306A40-B4EB-45FC-82C3-B5EB06A7BBFDQ58794306-DB151A76-3AA2-4A9A-AAE1-AA62D78E70FC
P2860
Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Surveillance of macrolide-resi ...... jing, China, from 2008 to 2012
@ast
Surveillance of macrolide-resi ...... jing, China, from 2008 to 2012
@en
type
label
Surveillance of macrolide-resi ...... jing, China, from 2008 to 2012
@ast
Surveillance of macrolide-resi ...... jing, China, from 2008 to 2012
@en
prefLabel
Surveillance of macrolide-resi ...... jing, China, from 2008 to 2012
@ast
Surveillance of macrolide-resi ...... jing, China, from 2008 to 2012
@en
P2093
P2860
P356
P1476
Surveillance of macrolide-resi ...... jing, China, from 2008 to 2012
@en
P2093
Fanliang Meng
Jianzhong Zhang
Xiaoxia Tao
P2860
P304
P356
10.1128/AAC.02060-12
P407
P577
2012-12-21T00:00:00Z